AU549457B2 - Dipeptide derivatives of disubstituted pyrrolidine - Google Patents

Dipeptide derivatives of disubstituted pyrrolidine

Info

Publication number
AU549457B2
AU549457B2 AU86454/82A AU8645482A AU549457B2 AU 549457 B2 AU549457 B2 AU 549457B2 AU 86454/82 A AU86454/82 A AU 86454/82A AU 8645482 A AU8645482 A AU 8645482A AU 549457 B2 AU549457 B2 AU 549457B2
Authority
AU
Australia
Prior art keywords
compound
methyl
hydroxy
prolyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU86454/82A
Other languages
English (en)
Other versions
AU8645482A (en
Inventor
Francis Richard Pfeiffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU8645482A publication Critical patent/AU8645482A/en
Application granted granted Critical
Publication of AU549457B2 publication Critical patent/AU549457B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
AU86454/82A 1981-09-09 1982-07-27 Dipeptide derivatives of disubstituted pyrrolidine Ceased AU549457B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/300,546 US4395401A (en) 1981-09-09 1981-09-09 Renally active dipeptides
US300546 1981-09-09

Publications (2)

Publication Number Publication Date
AU8645482A AU8645482A (en) 1983-03-17
AU549457B2 true AU549457B2 (en) 1986-01-30

Family

ID=23159558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86454/82A Ceased AU549457B2 (en) 1981-09-09 1982-07-27 Dipeptide derivatives of disubstituted pyrrolidine

Country Status (10)

Country Link
US (1) US4395401A (enExample)
EP (1) EP0074787B1 (enExample)
JP (1) JPS5874649A (enExample)
AT (1) ATE12349T1 (enExample)
AU (1) AU549457B2 (enExample)
DE (1) DE3262800D1 (enExample)
DK (1) DK362082A (enExample)
GR (1) GR76703B (enExample)
IE (1) IE54226B1 (enExample)
ZA (1) ZA825331B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
JPS62114957A (ja) * 1985-11-13 1987-05-26 Suntory Ltd プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジン誘導体およびその製法並びに用途
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
GB9023116D0 (en) * 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
BR9407933A (pt) * 1993-11-01 1996-11-26 Japat Ltd Antagonistas de receptores de endotelina
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
WO1998048826A1 (en) * 1997-04-30 1998-11-05 Northwestern University Inhibition of nitric oxide synthase by amino acids and dipeptides
KR100699404B1 (ko) * 1999-02-18 2007-03-23 가켄 세야쿠 가부시키가이샤 성장 호르몬 분비촉진제로서의 신규 아미드 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527932C2 (de) * 1974-07-02 1983-04-21 Pentapharm AG, 4052 Basel Säureadditionssalze von Tripeptidderivaten und deren Verwendung als Substrate zur Bestimmung von Plasmakallikrein
CH609154A5 (en) 1974-07-02 1979-02-15 Pentapharm Ag Method for the quantitative determination of proteolytic enzymes in body fluids from humans and mammals
JPS5827784B2 (ja) 1978-10-30 1983-06-11 鳥居薬品株式会社 アミノ酸誘導体

Also Published As

Publication number Publication date
US4395401A (en) 1983-07-26
IE54226B1 (en) 1989-07-19
JPS5874649A (ja) 1983-05-06
EP0074787A1 (en) 1983-03-23
IE822182L (en) 1983-03-09
DE3262800D1 (en) 1985-05-02
EP0074787B1 (en) 1985-03-27
DK362082A (da) 1983-03-10
AU8645482A (en) 1983-03-17
ATE12349T1 (de) 1985-04-15
ZA825331B (en) 1983-06-29
GR76703B (enExample) 1984-08-29

Similar Documents

Publication Publication Date Title
AU8645482A (en) Dipeptide derivatives of disubstituted pyrrolidine
AU588837B2 (en) Polypeptide
MY100343A (en) Amide derivative and external medicament comprising same
IE870610L (en) Hydroxylamine derivatives.
ATE66452T1 (de) Antineoplastische verbindungen.
AU570142B2 (en) Purine derivatives
AU5792694A (en) Filter carrier
AU7424587A (en) 2-Phenylbenzoxepin derivative
CA1266247C (en) ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067
AU6052086A (en) Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use
TNSN92069A1 (fr) Medicament a base de derives soufres neutralises
AU624962B2 (en) Ghilanten: antimetastatic principle from the south american leech, haementeria ghilanii
FR2598769B1 (fr) Garniture d'etancheite hydraulique ou pneumatique
AU4827085A (en) Method for treatment of antidiuresis employing serine derivatives
NZ219052A (en) Octahydroindolizine derivatives and pharmaceutical compositions
DK7286A (da) Octahydroindoliziner
AU4679985A (en) Neue immunwirksame verbindungen
AU7633987A (en) The use of 15-deoxyspergualine as a pharmaceutical
AU532890B2 (en) N-substituted morpholine derivatives
SU672430A1 (ru) Уплетнение разъемного неподвижного соединени
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят
ES8606271A1 (es) Procedimiento de preparacion de sulfonamidas con agrupacion imido
SU1233456A1 (ru) Способ получения замещенных n-[(1,3,5-триазин-2-ил)аминокарбонил]бензолсульфонамидов
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов
GB1468632A (en) Imidazolyl compounds and process for their manufacture